- Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. Jama. 2010;303(3):235-41.
- Braith RW, Stewart KJ. Resistance exercise training: its role in the prevention of cardiovascular disease. Circulation. 2006;113(22):2642-50.
- Matheus ASdM, Tannus LRM, Cobas RA, Palma CCS, Negrato CA, Gomes MdB. Impact of diabetes on cardiovascular disease: an update. International journal of hypertension. 2013;2013.
- Lelli D, Pedone C, Rossi F, Incalzi RA. Clinical and echocardiographic characteristics of elderly hospitalized patients with high levels of NT-proBNP without clinical diagnosis of heart failure. Aging clinical and experimental research. 2014;26(6):607-13.
- Cheng JM, Akkerhuis KM, Battes LC, van Vark LC, Hillege HL, Paulus WJ, et al. Biomarkers of heart failure with normal ejection fraction: a systematic review. European journal of heart failure. 2013;15(12):1350-62.
- Chen K, Jiang R, Wang C, Yin Z, Fan Y, Cao J, et al. Predictive value of plasma galectin-3 in patients with chronic heart failure. Eur Rev Med Pharmacol Sci. 2013;17(8):1005-11.
- Henderson NC, Sethi T. The regulation of inflammation by galectin‐3. Immunological reviews. 2009;230(1):160-71.
- Papaspyridonos M, McNeill E, de Bono JP, Smith A, Burnand KG, Channon KM, et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arteriosclerosis, thrombosis, and vascular biology. 2008;28(3):433-40.
- Dumic J, Dabelic S, Flögel M. Galectin-3: an open-ended story. Biochimica et Biophysica Acta (BBA)-General Subjects. 2006;1760(4):616-35.
- Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology. 2002;12(10):127R-36R.
- Pang J, Nguyen V, Rhodes D, Sullivan M, Braunschweig C, Fantuzzi G. Relationship of galectin-3 with obesity, IL-6, and CRP in women. Journal of endocrinological investigation. 2016;39(12):1435-43.
- Besler C, Lang D, Urban D, Rommel K-P, von Roeder M, Fengler K, et al. Plasma and Cardiac Galectin-3 in Patients With Heart Failure Reflects Both Inflammation and FibrosisCLINICAL PERSPECTIVE: Implications for Its Use as a Biomarker. Circulation: Heart Failure. 2017;10(3):e003804.
- Fujie S, Hasegawa N, Kurihara T, Sanada K, Hamaoka T, Iemitsu M. Association between aerobic exercise training effects of serum adropin level, arterial stiffness, and adiposity in obese elderly adults. Applied Physiology, Nutrition, and Metabolism. 2016;42(1):8-14.
- Shaw KA, Gennat HC, O'Rourke P, Del Mar C. Exercise for overweight or obesity. Cochrane database of systematic reviews. 2006(4).
- Cornelissen VA, Fagard RH. Effects of endurance training on blood pressure, blood pressure–regulating mechanisms, and cardiovascular risk factors. Hypertension. 2005;46(4):667-75.
- Thomas D. Thomas DE, Elliott EJ, Naughton GA. Exercise for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2006;3.
- Gram AS, Bladbjerg E-M, Skov J, Ploug T, Sjödin A, Rosenkilde M, et al. Three months of strictly controlled daily endurance exercise reduces thrombin generation and fibrinolytic risk markers in younger moderately overweight men. European journal of applied physiology. 2015;115(6):1331-8.
- Polák J. Úloha tukové tkáně v etiopatogenezi inzulínové rezistence. 2007.
- Salvagno GL, Schena F, Gelati M, Danese E, Cervellin G, Guidi GC, et al. The concentration of high-sensitivity troponin I, galectin-3 and NT-proBNP substantially increase after a 60-km ultramarathon. Clinical Chemistry and Laboratory Medicine (CCLM). 2014;52(2):267-72.
- Hättasch R, Spethmann S, de Boer RA, Ruifrok WP, Schattke S, Wagner M, et al. Galectin-3 increase in endurance athletes. European journal of preventive cardiology. 2014;21(10):1192-9.
- Khajeian N, Moghadasi M. Effect of 8 weeks regular endurance training on galectin-3 changes after a strenuous aerobic exercise.
- Billebeau G, Vodovar N, Sadoune M, Launay J, Beauvais F, Cohen-Solal A. Effects of a cardiac rehabilitation program on plasma cardiac biomarkers in patients with chronic heart failure. European Journal of Heart Failure. 2016;18:101-2.
- Siuf Jahromi M, Ebrahim K, Babaeibeigi M, Nikbakht H. Effect of Cardiac Rehabilitation with Severe Periodic Exercise Activity on Serum Glycine3 and Mutagenic Fraction in Patients with Heart Failure. Armaghane danesh. 2018;22(6):754-65.
- Trost SG, Owen N, Bauman AE, Sallis JF, Brown W. Correlates of adults’ participation in physical activity: review and update. Medicine & science in sports & exercise. 2002;34(12):1996-2001.
- Talanian JL, Galloway SD, Heigenhauser GJ, Bonen A, Spriet LL. Two weeks of high-intensity aerobic interval training increases the capacity for fat oxidation during exercise in women. Journal of applied physiology. 2007;102(4):1439-47.
- Cornish AK, Broadbent S, Cheema BS. Interval training for patients with coronary artery disease: a systematic review. European journal of applied physiology. 2011;111(4):579-89.
- Madsen EL, Rissanen A, Bruun JM, Skogstrand K, Tonstad S, Hougaard DM, et al. Weight loss larger than 10% is needed for general improvement of levels of circulating adiponectin and markers of inflammation in obese subjects: a 3-year weight loss study. European Journal of Endocrinology. 2008;158(2):179-87.
- Weston KS, Wisløff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J Sports Med. 2014;48(16):1227-34.
- Mitranun W, Deerochanawong C, Tanaka H, Suksom D. Continuous vs interval training on glycemic control and macro‐and microvascular reactivity in type 2 diabetic patients. Scandinavian journal of medicine & science in sports. 2014;24(2):e69-e76.
- Castro EA, Cupeiro R, Benito PJ, Calderón J, Fernández IR, Peinado AB. Peak oxygen uptake prediction in overweight and obese adults. Arch de Med del Dep. 2017;34(2):72-9.
- Issa SF, Christensen AF, Lottenburger T, Junker K, Lindegaard H, Horslev-Petersen K, et al. Within-day variation and influence of physical exercise on circulating Galectin-3 in patients with rheumatoid arthritis and healthy individuals. Scandinavian journal of immunology. 2015;82(1):70-5.
- Andonian BJ, Bartlett DB, Huebner JL, Willis L, Hoselton A, Kraus VB, et al. Effect of high-intensity interval training on muscle remodeling in rheumatoid arthritis compared to prediabetes. Arthritis Research & Therapy. 2018;20(1):283.
- Henderson NC, Mackinnon AC, Farnworth SL, Kipari T, Haslett C, Iredale JP, et al. Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. The American journal of pathology. 2008;172(2):288-98.
- Weigert J, Neumeier M, Wanninger J, Bauer S, Farkas S, Scherer MN, et al. Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetes. The Journal of Clinical Endocrinology & Metabolism. 2010;95(3):1404-11.
- Madrigal‐Matute J, Lindholt JS, Fernandez‐Garcia CE, Benito‐Martin A, Burillo E, Zalba G, et al. Galectin‐3, a biomarker linking oxidative stress and inflammation with the clinical outcomes of patients with atherothrombosis. Journal of the American Heart Association. 2014;3(4):e000785.
- Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, et al. Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation. 2004;110(19):3121-8.
- Hughes R. The galectin family of mammalian carbohydrate-binding molecules. Portland Press Limited; 1997.
- Kim H, Lee J, Hyun JW, Park JW, Joo Hg, Shin T. Expression and immunohistochemical localization of galectin‐3 in various mouse tissues. Cell biology international. 2007;31(7):655-62.
- Accattato F, Greco M, Pullano SA, Carè I, Fiorillo AS, Pujia A, et al. Effects of acute physical exercise on oxidative stress and inflammatory status in young, sedentary obese subjects. PLoS One. 2017;12(6):e0178900.
- Cavalcante PAM, Gregnani MF, Henrique JS, Ornellas FH, Araújo RC. Aerobic but not resistance exercise can induce inflammatory pathways via toll-like 2 and 4: a systematic review. Sports medicine-open. 2017;3(1):42.
- Henriquez-Olguin C, Renani LB, Arab-Ceschia L, Raun SH, Bhatia A, Li Z, et al. NADPH-oxidase 2 is required for molecular adaptations to high-intensity interval training in skeletal muscle. BioRxiv. 2019:542514.
- Bessa AL, Oliveira VN, G. Agostini G, Oliveira RJS, Oliveira ACS, White GE, et al. Exercise Intensity and Recovery: Biomarkers of Injury, Inflammation, and Oxidative Stress. The Journal of Strength & Conditioning Research. 2016;30(2):311-9.
|